JR has served on advisory panels for Applied Therapeutics, Boehringer Ingelheim, Eli Lilly, Hanmi, Intarcia, Novo Nordisk, Oramed, Sanofi, Structure Therapeutics, Terns Pharma and Zealand
The Key Distinction is Dose Rybelsus maxes out at 14 mg dailyenough for glycemic control, but the weight loss at that dose is modest (typically 3-4%)
Psychologically, theres an appeal: a way to get weight-loss benefits with fewer downsides sounds like the best of both worlds
Instead, reach out to your PlexusDx provider to discuss dose reduction, timing adjustments, or switching to oral semaglutide ($289/mo) if injections become intolerable
A clinical strategy designed for durability GLP-1 medications like Wegovy and Zepbound are powerful but only when used strategically